Jeffrey Rosenbloom, MD
Otolaryngology · San Antonio, TXNPI 1386652378
Payments from drug & device makers
Across 246 payments — averaging $2925.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$235K
- GSK$185K
- Aerin Medical Inc.$94K
- Eli Lilly$66K
- Intersect ENT, Inc.$55K
- Hill Dermaceuticals, Inc.$24K
- plus $59K from 19 others
Across 4 payments — averaging $2879.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurent Medical Limited$11K
- Intersect ENT, Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 35 | $235,404 |
| GSK | 43 | $184,637 |
| Aerin Medical Inc. | 20 | $94,399 |
| Eli Lilly | 2 | $66,381 |
| Intersect ENT, Inc. | 13 | $55,311 |
| Hill Dermaceuticals, Inc. | 1 | $24,363 |
| Acclarent, Inc | 39 | $18,718 |
| Sanofi | 3 | $12,324 |
| Medtronic | 15 | $11,435 |
| Insmed, Inc. | 2 | $9,000 |
| Optinose US, Inc. | 26 | $5,322 |
| Ambu Inc. | 1 | $900 |
| Regeneron Healthcare Solutions, Inc. | 25 | $810 |
| Carl Zeiss Meditec USA, Inc. | 1 | $148 |
| Alk-abello, Inc | 6 | $119 |
| Sanofi-aventis U.S. LLC | 4 | $87 |
| Phathom Pharmaceuticals, Inc. | 2 | $34 |
| Checkpoint Surgical, Inc | 1 | $29 |
| Stryker | 1 | $25 |
| Itamar Medical Inc | 1 | $24 |
| Neurent Medical Limited | 1 | $22 |
| Merck | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Smith+Nephew | 1 | $17 |
How this compares
$719,567 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in San Antonio
- Philip ChenSan Antonio$325K
- Nathan HalesSan Antonio$226K
- James AtkinsSan Antonio$205K
- Laurence ChuAustin$37.4M
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Chad McDuffieFrisco$1.5M
- Ian AlexanderBoerne$999K
- Stephen LaiHouston$968K
- Benjamin CilentoSpring$963K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.